In a Phase 2 trial, the highest doses produced an average ~24% body-weight reduction at 11 months (American Diabetes Association)
Don't judge your exercise capacity during the first month of a new dose
The press materials hint that Roche is scanning a large number of images and using AI to provide clinical decision support, though details remain proprietary ( [38] )
The drug also targets GLP-1 and GIP, but instead of stimulating GIP receptors, MariTide blocks them
If you have insurance that covers tirzepatide or GLP-1 medications, you may save more going through a traditional provider or pharmacy
Typically , clinical trials show users losing up to 15% of their body weight, leading to improvements in blood pressure and cholesterol